Market Tracker

08/22 9:45am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

113.86
Real-Time Quote
 +0.05 / +0.04%
Today’s Change
95.28
Today|||52-Week Range
153.10
-3.02%
Year-to-Date

Today’s Trading

Previous close113.81
Today’s open113.45
Day’s range113.20 - 113.60
Volume1,600
Average volume (3 months)3,298,613
Market cap$38.0B
Dividend yield--
Data as of 9:30am ET, 08/22/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+28.64%
Earnings growth (next 5 years)+34.80%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book7.40

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-0.95-0.57%
SHPGShire PLC-1.56-0.64%
AGNAllergan Inc-0.45-0.27%
VRTXVertex Pharmaceutica...+0.19+0.21%
Data as of 9:45am ET, 08/22/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$1.98
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts